Autopsy report · NCT05473442

Study of EQU-001 for Uncontrolled Focal Onset Seizures

“insufficient funding to complete the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 6 months before it stopped.
• 27 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Equilibre Biopharmaceuticals B.V.

Sponsor type

Industry

Conditions

Focal Onset Seizures

Interventions

EQU-001; Matching Placebo

Participants

27

Sites

13

Countries

Israel, United States

Trials that died the same way

• Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
  “Lack of funding to support the study” (91% match in meaning)
• Midodrine Use in Septic Shock
  “No funding for the study; not enough staff” (88% match in meaning)
• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (87% match in meaning)
• Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
  “Unable to obtain funding to initiate/complete study” (86% match in meaning)
• Augmented Reality-based Telerehabilitation Platform for Patients With Stroke
  “Study did not receive funding” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.